China Pharma

CPHINYSE China Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$28.825 M

$0.67 -1.69%

Close of 22 Sept 2026

Revenue

$4.14M

#3322 by revenue

Earnings

-$3.19M

Loss-making

Shares outstanding

43,022,002

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#380Kyntra BioKYNB$29.5M
#381IGC PharmaIGC$29.3M
#382China PharmaCPHI$28.8M
#383Optimi HealthOPTH$28.4M
#384GridAI TechnologiesGRDX$27.7M

What if China Pharma were worth as much as…

Open the what-if tool →

Gold $30.2T

$702,756.00

Per share 1,048,890× higher

Bitcoin $1.74T

$40,482.89

Per share 60,422× higher

Nvidia $5.52T

$128,208.05

Per share 191,355× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for China Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.